Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAydın, Taliha H.
dc.contributor.authorCan, Özgür Devrim
dc.contributor.authorÖzkay, Ümide Demir
dc.contributor.authorTuran, Nazlı
dc.date.accessioned2019-10-19T14:16:24Z
dc.date.available2019-10-19T14:16:24Z
dc.date.issued2016
dc.identifier.issn0767-3981
dc.identifier.issn1472-8206
dc.identifier.urihttps://dx.doi.org/10.1111/fcp.12224
dc.identifier.urihttps://hdl.handle.net/11421/13150
dc.descriptionWOS: 000387597900007en_US
dc.descriptionPubMed ID: 27421789en_US
dc.description.abstractIn this study, we investigated the effects of subacute agomelatine (40 and 80 mg/kg) administration on chronic hyperglycemia, metabolic parameters, and pain perception in streptozotocin-induced diabetic rats. Fasting blood glucose measurements and oral glucose tolerance tests were performed to evaluate the effect of agomelatine on glycemia, while metabolic parameters were monitored using metabolic cages. Potential effect of agomelatine on diabetes-induced mechanical and thermal allodynia was evaluated using dynamic plantar aesthesiometer and warm plate (38 degrees C) tests, respectively. Additionally, influence of agomelatine on hyperalgesia occurring in connection with diabetic neuropathy was examined using the Randall-Selitto (mechanical nociceptive stimulus), Hargreaves (thermal nociceptive stimulus), and cold plate (4 degrees C, thermal nociceptive stimulus) tests. Obtained data indicated that, in diabetic rats, agomelatine significantly improved hyperalgesia and allodynia responses, without no effect on hyperglycemia or the associated polydipsia, polyuria, and hyperphagia. Therapeutic potential of agomelatine on neuropathic pain was suppressed with -methyl-para-tyrosine methyl ester (an inhibitor of catecholamine synthesis), phentolamine (a nonselective -adrenoceptor antagonist), and propranolol (a nonselective -adrenoceptor antagonist) administrations. However, p-chlorophenylalanine methyl ester (an inhibitor of serotonin synthesis) pretreatment could not be achieved to reverse these antihyperalgesic and antiallodynic effects. These results suggest that the curative effect of agomelatine on neuropathic pain is mediated through rising synaptic catecholamine levels as well as through interactions with both - and -adrenoceptors. To our knowledge, this is the first study to show findings that indicate catecholaminergic system mediated antihyperalgesic and antiallodynic effects of agomelatine.en_US
dc.description.sponsorshipAnadolu University Research Foundation (Eskisehir, Turkey) [1105S084]en_US
dc.description.sponsorshipThis work was financially supported by the Anadolu University Research Foundation (Eskisehir, Turkey), Project No. 1105S084.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/fcp.12224en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdrenoceptoren_US
dc.subjectAgomelatineen_US
dc.subjectAllodyniaen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectHyperalgesiaen_US
dc.subjectNeuropathyen_US
dc.titleEffect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanismsen_US
dc.typearticleen_US
dc.relation.journalFundamental & Clinical Pharmacologyen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmakoloji Anabilim Dalıen_US
dc.identifier.volume30en_US
dc.identifier.issue6en_US
dc.identifier.startpage549en_US
dc.identifier.endpage567en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorCan, Özgür Devrim
dc.contributor.institutionauthorÖzkay, Ümide Demir


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster